Corcept Therapeutics | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Alaunos Therapeutics USD 2.72M 1.05M 2024-09
ANI Pharmaceuticals USD 403.68M 2.27M 2024-12
Ardelyx USD 173.29M 14.99M 2024-12
Aurora Cannabis CAD 572.92M 29.75M 2024-12
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Canopy Growth CAD 591.48M 81.81M 2024-12
Corcept Therapeutics USD 679.59M 40.75M 2024-12
Eli Lilly USD 14.19B 47.9M 2024-12
J&J USD 71.49B 1.33B 2024-12
Knight Therapeutics CAD 773.91M 11.11M 2024-09
Merck USD 46.31B 1.81B 2024-12
Novartis USD 44.05B 605M 2024-12
Novartis USD 44.05B 729M 2024-12
Pacira USD 778.35M 28.76M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Supernus Pharmaceuticals USD 1.04B 28.58M 2024-12
TG Therapeutics USD 222.36M 30.21M 2024-12



Corcept Therapeutics Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.